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Introduction
Acute kidney injury (AKI) is a common complication
after cardiac surgical procedures and is associated with
an increased morbidity and mortality.
Objective
In a multicenter randomized trial, we found that remote
ischemic preconditioning (RIPC) reduced acute kidney
injury (AKI) in high risk patients undergoing cardiac
surgery. We now report on the effects of RIPC on long-
term outcomes.
Methods
In this follow up of the RenalRIPC trial, we examined the
effect of RIPC the composite end-point of all-cause mor-
tality, need for renal replacement therapy, and persistent
renal dysfunction at 90 days (MAKE90). Secondary out-
comes were renal recovery and dialysis dependence in
patients with AKI.
Results
RIPC significantly reduced the occurrence of MAKE90
(17/120 (14.2%)) compared to the sham group (30/120
(25.0%); ARR, 10.8%, 95% CI 0.9%-20.8%, P = 0.034). In
the 108/240 patients who developed post-surgery AKI
(RIPC 45 (37.5%), Sham-RIPC 63 (52.5%)), 2 (5.3%) in
the RIPC group and 11 (22.0%) in the Sham-RIPC did
not recovery renal function by 90-days; ARR 16.7%, 95%
CI, 3.2%-30.2%, P = 0.028) and 1 (2.4%) versus 8 (15.4%)
were dialysis dependent; ARR 13.0%, 95% CI, 2.1%-23.8%,
P = 0.036). A receiver operating characteristic (ROC)
curve analysis for the MAKE90 showed best performance
for insulin-like growth factor-binding protein 7 (IGFBP7)
and tissue inhibitor of metalloproteinases-2 (TIMP-2)
([TIMP-2]·[IGFBP7]) at 4 h (AUC 0.64; 95% CI 0.547-
0.736, P = 0.004). The ROC analyses including AKI
positive patients showed that [TIMP-2]·[IGFBP7] was
predictive at 4h for renal non-recovery (AUC 0.70; 95%
CI, 0.587-0.818; P = 0.021) and at 12 h (AUC 0.74; 95%
CI, 0.604-0.879; P = 0.006) after cardiopulmonary
bypass. The maximum urinary [TIMP-2]·[IGFBP7]
demonstrated an AUC of 0.75 (95% CI, 0.640-0.865; P =
0.004). Optimal cut points were determined from the
ROC analyses maximizing the Youden Index ([TIMP-
2]·[IGFBP7] at 4h = 0.7; [TIMP-2]·[IGFBP7] at 12h =
0.67, [TIMP-2]·[IGFBP7] maximum = 0.86). Sensitivities
ranged from 0.50 to 0.55, specificities from 0.75 to 0.82.
Conclusions
RIPC significantly reduced the 3-month incidence of a
composite end point of all-cause mortality, need for
renal replacement therapy, and persistent renal dysfunc-
tion in high risk patients undergoing cardiac surgery.
Furthermore, RIPC enhanced renal recovery in patients
with AKI.
Trial Registration
The trial is registered at http://www.drks.de (Identifier:
DRKS00005333).
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